Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
February 4, 2011
Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening
Paolo Cappella, Maria Laura Giorgini, Claudia Ernestina Re, et al.
Gene
|
September 15, 2011
Transcriptional analysis of the Aurora inhibitor Danusertib leading to biomarker identification in TP53 wild type cells
Roberta Bosotti, Patrizia Carpinelli, Sandra Healy, et al.
Cancer Research
|
June 11, 2009
Quantitative assessment of the complex dynamics of G1, S, and G2-M checkpoint activities
Paolo Ubezio, Monica Lupi, Davide Branduardi, et al.
The Journal of Biological Chemistry
|
February 24, 2010
Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase
Claudia Perrera, Riccardo Colombo, Barbara Valsasina, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2011
5-(2-amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors
Michele Caruso, Barbara Valsasina, Dario Ballinari, et al.
Plos One
|
November 15, 2021
Neuroinflammation, body temperature and behavioural changes in CD1 male mice undergoing acute restraint stress: An exploratory study
Veronica Redaelli, Alice Bosi, Fabio Luzi, et al.
Plos One
|
October 29, 2015
A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing Compounds
Marta Durlak, Cristina Fugazza, Sudharshan Elangovan, et al.
Anticancer Research
|
December 29, 2010
Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo
Ulisse Cucchi, Laura M Gianellini, Anna De Ponti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2006
PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity
Chiara Soncini, Patrizia Carpinelli, Laura Gianellini, et al.
Cancer Research
|
December 17, 2010
Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase
Riccardo Colombo, Marina Caldarelli, Milena Mennecozzi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
February 4, 2011
Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening
Paolo Cappella, Maria Laura Giorgini, Claudia Ernestina Re, et al.
Gene
|
September 15, 2011
Transcriptional analysis of the Aurora inhibitor Danusertib leading to biomarker identification in TP53 wild type cells
Roberta Bosotti, Patrizia Carpinelli, Sandra Healy, et al.
Cancer Research
|
June 11, 2009
Quantitative assessment of the complex dynamics of G1, S, and G2-M checkpoint activities
Paolo Ubezio, Monica Lupi, Davide Branduardi, et al.
The Journal of Biological Chemistry
|
February 24, 2010
Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase
Claudia Perrera, Riccardo Colombo, Barbara Valsasina, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2011
5-(2-amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors
Michele Caruso, Barbara Valsasina, Dario Ballinari, et al.
Plos One
|
November 15, 2021
Neuroinflammation, body temperature and behavioural changes in CD1 male mice undergoing acute restraint stress: An exploratory study
Veronica Redaelli, Alice Bosi, Fabio Luzi, et al.
Plos One
|
October 29, 2015
A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing Compounds
Marta Durlak, Cristina Fugazza, Sudharshan Elangovan, et al.
Anticancer Research
|
December 29, 2010
Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo
Ulisse Cucchi, Laura M Gianellini, Anna De Ponti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2006
PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity
Chiara Soncini, Patrizia Carpinelli, Laura Gianellini, et al.
Cancer Research
|
December 17, 2010
Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase
Riccardo Colombo, Marina Caldarelli, Milena Mennecozzi, et al.
Page
of 3